Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Waldencast Acquisition (WALD)
NASDAQ:WALD
Holding WALD?
Track your performance easily
Earnings Data
Report Date
Jan 21, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.05Last Year’s EPS
-0.12Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 10, 2022
|% Change Since: -11.73%
|Next Earnings Date:Aug 11, 2022
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter with significant revenue and profit growth across both key brands, Obagi Medical and Milk Makeup. Despite some ongoing inventory challenges and regulatory investigation costs, the company is optimistic about future growth and strategic initiatives.Company Guidance
During the Waldencast Q3 2024 earnings call, the company provided optimistic guidance based on strong financial performance and strategic initiatives. The company reported a 34.6% increase in comparable net revenue, with Obagi Medical and Milk Makeup brands growing by 45.5% and 23.5%, respectively. Adjusted EBITDA rose by 134%, reaching 16.3% of net revenue, and the adjusted gross margin expanded by 400 basis points to 73.2%. The company reaffirmed its fiscal 2024 outlook, expecting comparable net revenue growth to accelerate beyond the 25.7% seen in Q2, with adjusted EBITDA margins landing in the mid-teens range. The call emphasized the strength of their operational platform and strategic growth initiatives, including international expansion and innovation in product offerings, with a focus on maintaining strong marketing investments to drive future growth.Strong Revenue Growth
Net revenue was $70.2 million, representing a 34.6% increase in comparable growth. Obagi Medical and Milk Makeup achieved 45.5% and 23.5% growth, respectively.
Adjusted EBITDA Increase
Adjusted EBITDA of $11.4 million, more than doubling with a 134% increase from Q3 last year, and adjusted EBITDA margin expanded 720 basis points year-over-year to 16.3%.
Obagi Medical Performance
Obagi Medical recorded net revenue of $38.7 million in Q3, representing comparable growth of 45.5% from the prior year third quarter.
Milk Makeup Expansion
Milk Makeup net revenue of $31.5 million, an increase of 23.5% year-over-year, with expansion into four new international retailers.
Improved Gross Margin
Adjusted gross profit margin rose 400 basis points to 73.2% in Q3 2024.
---
WALD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
WALD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 20, 2024 | $3.41 | $3.44 | +0.88% |
| Aug 27, 2024 | $2.90 | $3.06 | +5.52% |
| May 21, 2024 | $4.35 | $4.91 | +12.87% |
| Apr 30, 2024 | $5.07 | $4.87 | -3.94% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Waldencast Acquisition (WALD) report earnings?
Waldencast Acquisition (WALD) is schdueled to report earning on Jan 21, 2025, TBA Not Confirmed.
What is Waldencast Acquisition (WALD) earnings time?
Waldencast Acquisition (WALD) earnings time is at Jan 21, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is WALD EPS forecast?
WALD EPS forecast for the fiscal quarter 2024 (Q4) is -0.05.
---